Lipocine Inc (LPCN) stock is lower by -49.38% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary scoring system, gives LPCN stock a score of 59 out of a possible 100.
That score is influenced by a fundamental score of 84. In addition to the average rating from Wall Street analysts, LPCN stock has a mean target price of $5.67. This means analysts expect the stock to rise 600.00% over the next 12 months. LPCN’s score also includes a long-term technical score of 60. The short-term technical score for LPCN is 32.
What’s Happening with LPCN Stock Today
Lipocine Inc (LPCN) stock is down -70.41% while the S&P 500 is lower by -0.25% as of 12:31 PM on Monday, Nov 11. LPCN is lower by -$1.92 from the previous closing price of $2.73 on volume of 5,408,557 shares. Over the past year the S&P 500 has gained 13.17% while LPCN is lower by -49.38%. LPCN lost -$0.55 per share in the over the last 12 months.
